Veerappan has over 30 years of experience in the pharmaceutical industry and has developed and commercialized in excess of 200 specialty drug products. Prior to founding GAVIS, Veerappan founded Kali Laboratories, Inc. in 1997. He grew Kali from a developmental company to a full service pharmaceutical company which he sold to Par Pharmaceutical, Inc. in 2004. Veerappan continued to serve as Executive Vice President of Par until 2006, helping to transition Kali Labs into Par. Prior to founding Kali Labs, Veerappan was Vice President of Scientific Affairs at IVAX/Zenith Laboratories from 1990 until 1996. He joined Zenith as part of the executive team responsible for revitalizing and developing the company which was ultimately sold to IVAX in 1994 for over $600 million. From 1984 to 1990, Veerappan was Director of Product Development and Technical Services at Purepac Pharmaceuticals where he developed and commercialized over 50 specialty pharmaceutical drug products. Veerappan worked at Johnson & Johnson as a Senior Scientist from 1978 to 1980 and as a Senior Scientist for Richard Vicks from 1981 to 1984. From 1973 to 1975, Veerappan worked in India for a division of Squibb.
Veerappan has both a Bachelors and a Masters degree in Pharmacy. In 1981, he received his Ph.D. in Pharmacy from Rutgers University in New Jersey. He is a registered pharmacist in New York and New Jersey.